Spero Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Bostonmassachusettsfounded In 2013The Company Is Dedicated To Developing Innovative Therapies For Rare Diseases And Multidrug Resistant Bacterial Infectionsits Mission Is To Provide Differentiated Medicines That Improve Patient Outcomesparticularly For Those With Limited Treatment Options One Of Spero S Key Products Is Tebipenem Hbran Investigational Oral Carbapenem Antibiotic Aimed At Treating Complicated Urinary Tract Infections And Acute Pyelonephritisif Approvedit Would Be The First Oral Carbapenem For These Conditionspotentially Reducing The Need For Hospitalizationsspero Actively Pursues Partnerships To Enhance The Development And Reach Of Its Therapiesincluding Collaborations With Major Pharmaceutical Companies Spero Therapeutics Has Been Recognized As One Of Bostonae S Best Places To Workreflecting Its Commitment To A Mission Driven Corporate Culturethe Company Emphasizes Hope For Patients And Caregiversaligning With Its Name Derived From The Latin Word Forhope
